Member Database

Amy Pasternak

Clinical Assistant Professor
Clinical Pharmacy

PharmD, Ohio Northern University
PGY1 Pharmacy Practice Residency, Cleveland Clinic Hillcrest Hospital
PGY2 Clinical Pharmacogenetics Residency, St. Jude Children's Research Hospital
Clinical Pharmacy Translational Science Fellowship, University of Michigan College of Pharmacy

Dr. Pasternak earned her PharmD from the Ohio Northern University Raabe College of Pharmacy in 2014. After graduation, she completed a PGY-1 Pharmacy Practice Residency at Cleveland Clinic Hillcrest Hospital in Mayfield Heights, OH. She then pursued specialty training in clinical pharmacogenetics as the PGY-2 Clinical Pharmacogenetics Residency at St. Jude Children’s Research Hospital in Memphis, TN, and as a Clinical Pharmacy Translational Fellow at the University of Michigan College of Pharmacy. Dr. Pasternak joined the U-M faculty as a Clinical Assistant Professor in 2018. Her clinical practice is focused in the implementation of pharmacogenetics at Michigan Medicine and her research focuses on the discovery, validation, and translation of pharmacogenetic associations. Her current work is focused on pharmacogenetic associations of tacrolimus in multiple transplant populations and among routes of administration.


Optimization of pharmacogenetics at Michigan Medicine

Community and Professional Affiliation(s)

Clinical Pharmacogenetics Implementation Consortium

Research Area(s)

Clinical care | Clinical research | Drug Monitoring | Implementation | Pharmacogenomics


  • Principal investigator of: Impact of CYP2C19 genotype on proton pump inhibitor adverse events
  • Principal investigator of: Impact of CYP2C19 Genotype on Proton Pump Inhibitor (PPI) Adverse Reactions
  • Co-investigator of: Integration of DPYD onto Germline Genetic Testing in Patients with Early-stage Triple Negative Breast Cancer to Prevent Severe Capecitabine Toxicity. (997875)
View all grants